Address gastrointestinal symptoms proactively to reduce their impact on quality of life and mood
In TRIUMPH-1 and TRANSCEND-T2D-1, treatment with retatrutide resulted in substantial weight reduction together with clinically meaningful improvements in glycemia, knee osteoarthritis pain, and obstructive sleep apnea, with many individuals reaching what are classified as healthy-range weight and normal blood sugar levels. Retatrutide is an investigational once-weekly single molecule that activates the bodys receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon
Safety and effectiveness in pediatric patients have not been established
Prescription Eligibility Disclaimer: Completing an online quiz or intake form does not guarantee eligibility, approval, or a prescription
Generally, patients 12 and up can be evaluated for surgery and are eligible for GLP-1RA medications
For most people, the area around the belly button is an excellent spot